4.5 Review

The Extracellular Matrix Regulates Cancer Progression and Therapy Response: Implications for Prognosis and Treatment

Journal

CURRENT PHARMACEUTICAL DESIGN
Volume 15, Issue 12, Pages 1373-1384

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161209787846711

Keywords

-

Funding

  1. Fund for Scientific Research-Flanders (Brussels, Belgium) [FWOAL455]

Ask authors/readers for more resources

Emerging evidence points towards a key role of the extracellular matrix (ECM) during tumor progression and therapy resistance. Paradoxically, in today's routine of cancer management the ECM is not taken into account. It is the aim of the present review to broaden our understanding of the mechanisms of therapy resistance, taking the ECM as a presumptive central regulator. The stromal ecosystem drives the accumulation of ECM at the invasion front. Therefore, we address the question whether the detection of ECM signatures in histopathology and biofluids may help predicting therapy resistance and determining the prognosis of cancer. Since the ECM is an attractive target for tumor therapy, current therapeutic strategies in preclinical or clinical development will be discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Feasibility of Mechanical Extrusion to Coat Nanoparticles with Extracellular Vesicle Membranes

Jan Van Deun, Quentin Roux, Sarah Deville, Thibaut Van Acker, Pekka Rappu, Ilkka Miinalainen, Jyrki Heino, Frank Vanhaecke, Bruno G. De Geest, Olivier De Wever, An Hendrix

CELLS (2020)

Article Engineering, Biomedical

Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer

Flavia Castro, Marta L. Pinto, Catarina L. Pereira, Karine Serre, Mario A. Barbosa, Karim Vermaelen, Fatima Gartner, Raquel M. Goncalves, Olivier De Wever, Maria J. Oliveira

BIOMATERIALS (2020)

Review Oncology

Splenic Hematopoietic and Stromal Cells in Cancer Progression

Jonas Steenbrugge, Emiel A. De Jaeghere, Evelyne Meyer, Hannelore Denys, Olivier De Wever

Summary: Tumor-derived secretory factors influence splenic hematopoietic and stromal cells to promote tumor metastasis. While animal models provide valuable insights, translating these findings to clinical practice poses specific challenges.

CANCER RESEARCH (2021)

Article Oncology

Targeting USP13-mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non-small cell lung cancer

Philippe Giron, Carolien Eggermont, Amir Noeparast, Hugo Vandenplas, Erik Teugels, Ramses Forsyth, Olivier De Wever, Pedro Aza-Blanc, Gustavo J. Gutierrez, Jacques De Greve

Summary: The study identifies USP13 as a protein that can increase the sensitivity of lung cancer cells with EGFR mutations to targeted therapy, potentially improving treatment efficacy.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Chemistry, Medicinal

Marine Seagrass Extract of Thalassia testudinum Suppresses Colorectal Tumor Growth, Motility and Angiogenesis by Autophagic Stress and Immunogenic Cell Death Pathways

Ivones Hernandez-Balmaseda, Idania Rodeiro Guerra, Ken Declerck, Jose Alfredo Herrera Isidron, Claudina Perez-Novo, Guy Van Camp, Olivier De Wever, Kethia Gonzalez, Mayrel Labrada, Adriana Carr, Geovanni Dantas-Cassali, Diego Carlos dos Reis, Livan Delgado-Roche, Roberto Rafael Nunez, Rene Delgado-Hernandez, Miguel David Fernandez, Miriam T. Paz-Lopes, Wim Vanden Berghe

Summary: In vitro and in vivo studies demonstrated the antitumor effects of TTE on colon tumor cell lines and a murine colorectal cancer model, including suppression of cell growth, migration, and angiogenesis, as well as promotion of antitumor immunogenic cell death. Transcription profiling and pathway analysis revealed that TTE triggers specific gene expression and autophagy stress pathways, leading to its antitumor effects.

MARINE DRUGS (2021)

Article Biochemical Research Methods

Recombinant extracellular vesicles as biological reference material for method development, data normalization and assessment of (pre-)analytical variables

Edward Geeurickx, Lien Lippens, Pekka Rappu, Bruno G. De Geest, Olivier De Wever, An Hendrix

Summary: This study presents a protocol for using recombinant EV as a biological reference material to evaluate EV application performance, map technical variability, and promote inter-laboratory studies, which can be completed in about 4-5 days.

NATURE PROTOCOLS (2021)

Article Multidisciplinary Sciences

In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis

Valerie De Meulenaere, Benedicte Descamps, Olivier De Wever, Christian Vanhove, Karel Deblaere

PLOS ONE (2020)

Review Biochemistry & Molecular Biology

Delivery routes matter: Safety and efficacy of intratumoral immunotherapy

Emily De Lombaerde, Olivier De Wever, Bruno G. De Geest

Summary: Direct intratumoral injection allows for local immune activation, leading to decreased systemic toxicity, improved efficacy, and abscopal effects. The approval of the first intratumoral oncolytic virotherapy, talimogene laherparepvec (T-VEC), has sparked interest in studying other immunotherapeutic approaches.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Article Neurosciences

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

Ana Rita Pombo Antunes, Isabelle Scheyltjens, Francesca Lodi, Julie Messiaen, Asier Antoranz, Johnny Duerinck, Daliya Kancheva, Liesbet Martens, Karen De Vlaminck, Hannah Van Hove, Signe Schmidt Kjolner Hansen, Francesca Maria Bosisio, Koen Van der Borght, Steven De Vleeschouwer, Raf Sciot, Luc Bouwens, Michiel Verfaillie, Niels Vandamme, Roosmarijn E. Vandenbroucke, Olivier De Wever, Yvan Saeys, Martin Guilliams, Conny Gysemans, Bart Neyns, Frederik De Smet, Diether Lambrechts, Jo A. Van Ginderachter, Kiavash Movahedi

Summary: By utilizing single-cell RNA sequencing and CITE-seq, this study reveals the complexity of the immune landscape in glioblastomas, including conserved populations of dendritic cells and macrophages. The results indicate that microglia-derived tumor-associated macrophages dominate in newly diagnosed tumors, but are replaced by monocyte-derived TAMs in recurrences.

NATURE NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance

Catalina Lodillinsky, Laetitia Fuhrmann, Marie Irondelle, Olena Pylypenko, Xiao-Yan Li, Helene Bonsang-Kitzis, Fabien Reyal, Sophie Vacher, Claire Calmel, Olivier De Wever, Ivan Bieche, Marie-Lise Lacombe, Ana Maria Eijan, Anne Houdusse, Anne Vincent-Salomon, Stephen J. Weiss, Philippe Chavrier, Mathieu Boissan

Summary: The study reveals that NME1 plays a crucial role in the in situ-to-invasive transition of breast cancer, showing a negative correlation with MT1-MMP and impacting the invasive potential of breast cancer cells.

ONCOGENE (2021)

Article Chemistry, Multidisciplinary

In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes

Yentl Van Rymenant, Muhammet Tanc, Roos Van Elzen, An Bracke, Olivier De Wever, Koen Augustyns, Anne-Marie Lambeir, Mark Kockx, Ingrid De Meester, Pieter Van Der Veken

Summary: Fibroblast activation protein (FAP) is a proline-selective protease highly expressed in the tumor microenvironment, and selective activity-based probes have been developed to detect FAP with subnanomolar affinity and selectivity. These probes are suitable for biological studies and have been tested for in situ FAP activity staining in patient-derived cryosections of urothelial tumors.

FRONTIERS IN CHEMISTRY (2021)

Article Oncology

OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer

Jonas Steenbrugge, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek N. Sanders, Wim van den Broeck, Eric Ciamporcero, Timothy Perera, Evelyne Meyer

Summary: c-MET plays a crucial role in cancer progression, and OMO-1, a potent c-MET inhibitor, shows promising therapeutic efficacy in TNBC. OMO-1 not only reduces tumor progression dose dependently but also enhances the effects of cisplatin, providing potential benefits for TNBC patients, even in cases of non-c-MET addicted tumors.

NPJ BREAST CANCER (2021)

Article Materials Science, Biomaterials

Cytosolic delivery of gadolinium via photoporation enables improved in vivo magnetic resonance imaging of cancer cells

Aranit Harizaj, Benedicte Descamps, Christophe Mangodt, Stephan Stremersch, Arianna Stoppa, Lieve Balcaen, Toon Brans, Hilde De Rooster, Nausikaa Devriendt, Juan C. Fraire, Eduardo Bolea-Fernandez, Olivier De Wever, Wouter Willaert, Frank Vanhaecke, Christian V. Stevens, Stefaan C. De Smedt, Bart Roman, Christian Vanhove, Ine Lentacker, Kevin Braeckmans

Summary: Longitudinal in vivo monitoring of transplanted cells is crucial for cancer research and treatment assessment. MRI offers high spatial resolution and soft-tissue contrast, but suffers from low sensitivity, requiring high concentrations of contrast agents. Photoporation provides an attractive alternative for efficient delivery of contrast agents into the cytosol, avoiding the quenching effect and improving MR signal intensity.

BIOMATERIALS SCIENCE (2021)

Article Oncology

Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Emiel A. De Jaeghere, Frederiek Laloo, Lien Lippens, Mieke Van Bockstal, Kathia De Man, Eline Naert, Jo Van Dorpe, Koen Van de Vijver, Philippe Tummers, Amin Makar, Pieter J. L. De Visschere, Olivier De Wever, Frederic Amant, Hannelore G. Denys, Katrien Vandecasteele

GYNECOLOGIC ONCOLOGY (2020)

Article Biochemical Research Methods

Preparation of Multi-omics Grade Extracellular Vesicles by Density-Based Fractionation of Urine

Bert Dhondt, Nicolaas Lumen, Olivier De Wever, An Hendrix

STAR PROTOCOLS (2020)

No Data Available